VanEck Associates’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-111,205
| Closed | -$3.78M | – | 822 |
|
|
2015
Q2 | $3.78M | Sell |
111,205
-32,402
| -23% | -$1.1M | 0.02% | 293 |
|
|
2015
Q1 | $5.08M | Buy |
143,607
+14,018
| +11% | +$496K | 0.03% | 269 |
|
|
2014
Q4 | $4.41M | Buy |
129,589
+5,280
| +4% | +$180K | 0.03% | 274 |
|
|
2014
Q3 | $4.8M | Sell |
124,309
-5,716
| -4% | -$220K | 0.03% | 249 |
|
|
2014
Q2 | $5.06M | Sell |
130,025
-37,857
| -23% | -$1.47M | 0.02% | 248 |
|
|
2014
Q1 | $5.74M | Sell |
167,882
-33,119
| -16% | -$1.13M | 0.03% | 227 |
|
|
2013
Q4 | $4.22M | Buy |
201,001
+10,247
| +5% | +$215K | 0.02% | 244 |
|
|
2013
Q3 | $4.48M | Buy |
190,754
+3,235
| +2% | +$76K | 0.02% | 238 |
|
|
2013
Q2 | $5.04M | Buy |
+187,519
| New | +$5.04M | 0.03% | 218 |
|